OmniAb (OABI) Non Operating Investment Income (2022)

OmniAb (OABI) reported Non Operating Investment Income of $1.1 million for Q3 2022, up 267.13% quarter-over-quarter from $297047.0 in Q2 2022.

OmniAb (OABI) Non Operating Investment Income (2022) Analysis & Trends

OmniAb (OABI) has 1 years of Non Operating Investment Income data on file, last reported at $1.1 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	235,807.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	230,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	OmniAb	294.96 Mn	252.00 Mn	14.41 Mn	-

Download Data